跳至主要内容
临床试验/CTRI/2023/07/055248
CTRI/2023/07/055248尚未招募2 期

A Randomized Controlled Clinical study to evaluate the antipyretic effect of Febrikid Plus Tablets in children with febrile state. - nil

Parul Ayurveda Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Temperature between 99- 103 oF.
  • 2.Fever of acute onset without any complications i.e. dehydration, convulsion, etc.
  • 3.Acute onset fever of 1 to 3 days.
  • 4.Patient of either sex suffering from fever of age 3-12 years.
  • 5.Children with parents who agree to participate and sign the informed consent

排除标准

  • 1.Fever more than 3 days.
  • 2.Chronic fever ( > 5 days) associated with poor hemodynamic and clinical outcomes.
  • 3.Any febrile condition of children requiring an immediate intervention depending of history and general condition at the point of examination as found by the investigators non inducible was be excluded from study

研究者

发起方
Parul Ayurveda Hospital

相似试验